A.   Administer a second dose.

B.   Continue to monitor consciousness for 2 minutes.

C.   Provide another prescribed medication.

D.   Administer four doses at 15-second intervals.

A.   Zaleplon

B.   Ramelteon

C.   Zolpidem

D.   Eszopiclone

A.   Sleepwalking

B.   Dozing

C.   Deep sleep

D.   Relaxation

A.   Bedwetting

B.   Vivid dreams

C.   Daytime fatigue

D.   Sleepwalking

A.   Short-acting barbiturates

B.   Ultra-short-acting barbiturates

C.   Long-acting barbiturates

D.   Intermediate-acting barbiturates

A.   Cardiac disease

B.   Epileptic disease

C.   Drug allergy

D.   Narrow-angle glaucoma

A.   Reduction of muscle rigidity

B.   Reduction of choreiform movement

C.   Prevention of lightheadedness

D.   Relief of nerve pain

A.   Increased body weight

B.   Bedwetting

C.   Sleepwalking

D.   Increased perspiration

A.   Midazolam

B.   Eszopiclone

C.   Ramelteon

D.   Alprazolam

A.   Dantrolene

B.   Diazepam

C.   Cyclobenzaprine

D.   Baclofen

A.   Constipation

B.   Decreased heart rate

C.   Dry mouth

D.   Amnesia

A.   Rifampin

B.   Olanzapine

C.   Verapamil

D.   Flumazenil

A.   The drug acts on gamma-aminobutyric acid (GABA) receptors in the central nervous system (CNS).

B.   The drug may reduce the memory of painful symptoms related to alcohol withdrawal.

C.   The drug acts on benzodiazepine receptors that play a role in alcohol addiction.

D.   The patient may need to be sedated to relieve symptoms of alcohol withdrawal.

A.   Sulfamethoxazole

B.   Ceftriaxone

C.   Phenobarbital

D.   Oxytocin

A.   Butabarbital

B.   Pentobarbital

C.   Phenobarbital

D.   Mephobarbital

A.   Prolonged benzodiazepine action

B.   Increased central nervous system (CNS) depression

C.   Increased daytime sleepiness

D.   Decreased benzodiazepine effects

A.   Flumazenil

B.   Activated charcoal

C.   Furosemide

D.   Olanzapine

A.   Suppression of gamma-aminobutyric acid (GABA) receptors

B.   Amnesic properties

C.   Presence of benzodiazepine receptors adjacent to the receptors responsible for alcohol addiction

D.   Inhibition of nerve impulse transmission

A.   Recommending that the patient consume a glass of warm lactose-free milk at bedtime

B.   Encouraging the patient to maintain a well-balanced diet

C.   Instructing the patient to take low doses of benzodiazepines

D.   Teaching the patient about meditation

A.   Phenylephrine at a maximum dose of 2 mg

B.   Flumazenil at a maximum dose of 3 mg

C.   Flumazenil at a maximum dose of 1 mg

D.   Phenylephrine at a maximum dose of 5 mg

A.   The patient was administered azole along with benzodiazepine.

B.   The patient is experiencing a muscle-relaxant overdose.

C.   The patient is experiencing benzodiazepine toxicity.

D.   The patient is experiencing a barbiturate overdose.

A.   Ramelteon

B.   Zaleplon

C.   Diazepam

D.   Pentobarbital

A.   Avoiding tobacco at bedtime

B.   Sleeping more during the day

C.   Establishing a set sleep pattern

D.   Avoiding alcohol at bedtime

A.   Temazepam

B.   Diazepam

C.   Midazolam

D.   Flurazepam

A.   Hallucinations

B.   Ataxia

C.   Alertness

D.   Dyspnea

A.   Ipecac syrup

B.   Naloxone

C.   Flumazenil

D.   Activated charcoal

A.   Duration of action on the central nervous system (CNS)

B.   Degree of patient responsiveness to the drug given

C.   Dose of the drug used to produce the effect on the CNS

D.   Degree of inhibition of nerve impulse transmission to the CNS

A.   Temazepam causes early awakening after sleep.

B.   Temazepam may cause gastrointestinal upset.

C.   Temazepam induces sleep in approximately 1 hour.

D.   The therapeutic activity of temazepam is reduced with sleep.

A.   Infusion that is too rapid

B.   Intravenous infiltration

C.   Infusion of other drugs

D.   Infusion without dilution

A.   Take lower doses of benzodiazepines.

B.   Go to acupuncture therapy.

C.   Drink lactose-free milk at bedtime.

D.   Use home remedies of vegetables and herbs.

A.   Diazepam, Ramelteon, Midazolam

B.   Diazepam, Midazolam, Eszopiclone

C.   Zolpidem, Diazepam, Midazolam

D.   Zolpidem, Ramelteon, Eszopiclone

A.   Maintenance of an adequate airway

B.   Administration of activated charcoal

C.   Administration of furosemide

D.   Administration of intravenous fluids

A.   "I will stop drinking coffee at least 6 hours before bedtime."

B.   "I will have a glass of warm milk before bed."

C.   "I should avoid exercise just before going to bed."

D.   "I may be prescribed benzodiazepines to promote sleep."

A.   Instruct the patient to increase the dosage of the contraceptive drug.

B.   Suggest an alternate contraceptive method to the patient.

C.   Recommend discussing an alternative drug for seizures with the primary health care provider.

D.   Request a prescription to increase the dosage of pentobarbital.

A.   Respiratory arrest

B.   Delirium tremens

C.   Malignant hyperthermia

D.   Tonic-clonic seizure

A.   Take the drug 30 minutes before sleeping.

B.   Avoid using this drug to induce sleep.

C.   Drink coffee or tea in the morning.

D.   Use the lowest effective dosage.

A.   Increases pain associated with activities

B.   Produces drowsiness, lethargy, and blurred vision

C.   Causes gastrointestinal distress

D.   Impairs coordinated movements

A.   Thiopental

B.   Butabarbital

C.   Pentobarbital

D.   Phenobarbital

A.   Significant respiratory difficulties, Hypotension, Status epilepticus

B.   Pregnancy, Drug allergy, Significant respiratory difficulties

C.   Hypotension, Status epilepticus, Pregnancy

D.   Hypotension, Drug allergy, Status epilepticus

A.   "Expect and prepare for a daytime hangover."

B.   "Report palpitations to the primary health care provider."

C.   "Allow at least 8 hours for sleep."

D.   "Take the medication with food or milk."

A.   Drinks grapefruit juice along with diazepam

B.   Takes olanzapine along with diazepam

C.   Takes phenobarbital along with diazepam

D.   Takes rifampin along with diazepam

A.   Tricyclic antidepressant, Monoamine oxidase inhibitor (MAOI), Atypical antidepressants

B.   Selective serotonin reuptake inhibitor (SSRI), Serotonin-norepinephrine reuptake inhibitor (SNRI), Atypical antidepressants

C.   Monoamine oxidase inhibitor (MAOI), Selective serotonin reuptake inhibitor (SSRI), Serotonin-norepinephrine reuptake inhibitor (SNRI)

D.   Selective serotonin reuptake inhibitor (SSRI), Tricyclic antidepressant, Serotonin-norepinephrine reuptake inhibitor (SNRI)

A.   Narrow-angle glaucoma

B.   Bronchial asthma

C.   Kidney dysfunction

D.   Liver dysfunction

A.   Clonazepam

B.   Temazepam

C.   Eszopiclone

D.   Alprazolam

A.   Pentobarbital

B.   Diazepam

C.   Zaleplon

D.   Baclofen

A.   Encouraging the patient to drink more fluids

B.   Assessing the patient’s risk for injury or falls

C.   Monitoring for suicidal tendencies

D.   Monitoring the patient’s renal and hepatic function

A.   Seizure precautions

B.   Antidote preparation

C.   Comfort measures

D.   Airway maintenance

A.   Level of consciousness

B.   Indicators of infection

C.   Muscle spasms

D.   Amount of bleeding

A.   Alcohol was consumed with the benzodiazepines.

B.   The half-life of flumazenil is short.

C.   A high dose of flumazenil was given.

D.   0.2 mg (2 mL) of flumazenil was given intravenously (IV).

A.   Alprazolam

B.   Eszopiclone

C.   Ramelteon

D.   Zaleplon

A.   "I feel like I breathe too deeply."

B.   "I sleep less than I used to."

C.   "Nowadays I sleep for long hours."

D.   "I often feel dizzy and lightheaded."

A.   0.2 mg (2 mL) IV over 15 seconds

B.   0.5 mg (5 mL) IV over 30 seconds

C.   0.2 mg (2 mL) IV over 60 seconds

D.   0.2 mg (2 mL) intravenously (IV) over 30 seconds